⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Protein Palmitoylation in Cardiovascular Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-17 — Palmitoylation in cardiovascular aging and disease: Mechanistic insights and therapeutic opportunities.: 2026 systematic review frames dysregulated protein palmitoylation under metabolic stress as a mechanistic driver of cardiovascular aging via mitochondrial dysfunction, impaired autophagy, oxidative stress, and senescence — proposing a palmitoylation-driven metabolic vicious-cycle model with putative therapeutic tractability; synthesis of cell/pathway evidence, no new primary data. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Palmitoylation in cardiovascular aging and disease: Mechanistic insights and therapeutic opportunities.
17-jul-2026
novelty 3
per-area 3
strengthens